Navigation Links
Barr Confirms Patent Challenge of Avodart(R) Soft Gelatin Capsules, 0.5mg
Date:2/26/2008

titive products and pricing on products, including the launch of authorized generics; the ability to launch new products in the timeframes we expect; the availability of raw materials; the availability of any product we purchase and sell as a distributor; the regulatory environment in the markets where we operate; our exposure to product liability and other lawsuits and contingencies; the increasing cost of insurance and the availability of product liability insurance coverage; our timely and successful completion of strategic initiatives, including integrating companies (such as PLIVA d.d.) and products we acquire and implementing our new SAP enterprise resource planning system; fluctuations in operating results, including the effects on such results from spending for research and development, sales and marketing activities and patent challenge activities; the inherent uncertainty associated with financial projections; our expansion into international markets through our PLIVA acquisition, and the resulting currency, governmental, regulatory and other risks involved with international operations; our ability to service our significantly increased debt obligations as a result of the PLIVA acquisition; changes in generally accepted accounting principles; and other risks detailed in our SEC filings, including in our Transition Report on Form 10-K/T for the six months ended December 31, 2006.

The forward-looking statements contained in this press release speak only as of the date the statement was made. The Company undertakes no obligation (nor does it intend) to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required under applicable law.


'/>"/>
SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Icahn Confirms Intention to Nominate Three Directors at Biogen
2. Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg
3. Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL
4. Barr Confirms Patent Challenge of Focalin(R) XR
5. Recent Study Confirms Alimentary Healths Bifantis(R) Demonstrates Efficacy in the Treatment of Irritable Bowel Syndrome
6. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
7. Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
8. Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
9. Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements
10. United States Patent Office Grants CryoCors Request for Patent Interference
11. AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014   BioTE ... therapy using natural, bio-identical hormone pellets, today announced ... MD to the company.   Dr. Rouzier is joining ... physician.      Dr. Rouzier was residency ... UCLA and is a board certified emergency physician ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 The ... clear and concise visual representation of history, migration, and ... was always regaled by family history stories stemming from ... as the "old country." Pictures and 8mm home movies ... side of the family, and Steve ordered a test ...
(Date:7/22/2014)... SHENZHEN , Cina, 22 luglio 2014 ... di BGI, la maggiore organizzazione di genomica del mondo, ... di sequenziamento dell,intero esoma umano con base la piattaforma ... Complete Genomics, molto apprezzata nel settore per essere in ... 99.999% di precisione e una rilevazione altamente sensibile di ...
(Date:7/22/2014)...  Semler Scientific, Inc. (Nasdaq: SMLR ... that develops patented products that assist healthcare providers ... announced that it will report second quarter 2014 ... markets on July 25, 2014. Doug Murphy-Chutorian, M.D., chief executive ... at 11 a.m. EDT, July 25, 2014. The ...
Breaking Biology Technology:Dr. Neal Rouzier Joins BioTE Medical 2Dr. Neal Rouzier Joins BioTE Medical 3DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 2DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 3DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 4BGI Tech lancia un servizio di sequenziamento dell'intero esoma umano sulla piattaforma avanzata di Complete Genomics 2Semler to Report Second Quarter 2014 Financial Results and Host Conference Call on July 25, 2014 2
... ... heat transfer fluid is a thermally stable, economical and high-performance solution for operations with ... ... new Paratherm GLT™ heat transfer fluid is a thermally stable, economical and high-performance solution ...
... , , , PHILADELPHIA ... Citation Laureates -- researchers likely to be in contention for Nobel honors -- ... economics to be announced from October 5-12. , , ... predictions of Nobel Prize winners. , , Each ...
... , PASADENA, Calif., Sept. 23 Alexandria ... today that it is commencing an underwritten public offering of ... and UBS Investment Bank are acting as joint bookrunning managers ... Equities, Inc. expects to grant the underwriters a thirty-day option ...
Cached Biology Technology:Paratherm's New GLT Heat Transfer Fluid: Thermally Stable & Lower Minimum Startup Temperatures 2Thomson Reuters Predicts Nobel Laureates 2Thomson Reuters Predicts Nobel Laureates 3Thomson Reuters Predicts Nobel Laureates 4Thomson Reuters Predicts Nobel Laureates 5Thomson Reuters Predicts Nobel Laureates 6Alexandria Real Estate Equities, Inc. Announces Public Follow-on Offering of 3,000,000 Shares of Common Stock 2Alexandria Real Estate Equities, Inc. Announces Public Follow-on Offering of 3,000,000 Shares of Common Stock 3
(Date:7/22/2014)... research team from the National Institute of Standards ... has demonstrated a dramatically improved technique for analyzing ... vibration "signatures." The new NIST technique is an ... spectroscopy, but one that delivers signals that are ... scattering, and 100 times stronger than obtained from ...
(Date:7/22/2014)... negative reputation as disease causing agents, some viruses ... help to shape the world we live in ... American Academy of Microbiology. , "Viruses participate in ... on the planet, from contributing to biogeochemical cycles, ... events," states Marilyn Roossinck of Pennsylvania State University, ...
(Date:7/22/2014)... much promise for treating damaged organs and tissues, but ... limiting their effectiveness. New methods are being developed and ... function after transplantation, as described in a Review article ... from Mary Ann Liebert, Inc., publishers. The article is ... website . , In the article ...
Breaking Biology News(10 mins):Enhanced NIST instrument enables high-speed chemical imaging of tissues 2Enhanced NIST instrument enables high-speed chemical imaging of tissues 3Report on viruses looks beyond disease 2
... Going about their day-to-day business, bees have no need ... when Adrian Dyer from Monash University trained the fascinating insects ... they seemed to be able to do just that. But ... that the bees weren,t learning to recognise people. ,Because the ...
... Va. New advances for the detection of cancer ... Forest School of Biomedical Engineering and Science (SBES) are ... 2010 Royal Society of Chemistry,s magazine, " Lab on ... microfluidics. http://www.rsc.org/Publishing/Journals/lc/index.asp Microfluidics is the behavior ...
... deadline of February 4th is only one week ... most important international osteoporosis meeting of the year, ... abstract online:, http://www.iofwco-ecceo10.org/abstracts/ Abstracts ... Osteoporosis International, with opportunity for poster presentation. Authors ...
Cached Biology News:Bees recognize human faces using feature configuration 2Bees recognize human faces using feature configuration 3Advances in cancer detection research by Virginia Tech engineer featured in British magazine 2Advances in cancer detection research by Virginia Tech engineer featured in British magazine 3
Spectrolyse (pL) PAI kit is a two-stage indirect enzymatic assay for the quantitative determination of Plasminogen Activator Inhibitor (PAI-1) activity in plasma. Sample Type: plasma...
NAK/TBK1 (CT) Affinity Purified Polyclonal Antibody...
... human cardiac troponin subunit T, a 31kDa protein ... contraction of cardiac muscle. It reacts with subunit ... It also cross-reacts with human skeletal troponin T ... Highly purified human cardiac troponin T ...
... is pleased to offer the ATTO-TAG ... detection of primary amines. Developed by ... the ATTO-TAG reagents are similar to ... (NDA) and anthracene-2,3-dicarboxaldehyde, all of which ...
Biology Products: